Alright, so you’ve heard of Ozempic, right? The “magic” weight loss drug that’s everywhere—TikTok, the news, probably y ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

As a player in the growing telehealth sector, Hims & Hers Health ($HIMS) has grown significantly, driving its stock up over ...

Stock prices used were end-of-day prices of Oct. 3, 2024. The video was published on Oct. 3, 2024. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst ...

As of October 3 at 11:50 AM EDT. Market Open.

The bold move has been accompanied by a full-page ad in the Wall Street Journal explaining its reasoning, and claiming that the prices of GLP-1 drugs for weight loss are five times too high and ...

Strong economic data boosts investor confidence, while geopolitical tensions and company news impact trending stocks.

Learn More Palantir's market price has soared in 2024, but this valuation method suggests the worth might be otherwise.

medications, and counseling, offer hope and improved quality of life, underlining the value of professional consultation for those experiencing sexual health concerns. Like erectile dysfunction, p ...